Liposome-encapsulated doxorubicin citrate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Liposome-encapsulated doxorubicin citrate, covering 2013-08-07 to 2013-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 2]